Clinical trials: be Enrolled in the Trial.
Consecutive Subjects Who Are Suitable for a Coronary, Angioplasty of de Novo Lesion(s) in Native Coronary
CRE8 in All Comers Patients
The purpose of the study is to evaluate clinical performances of Cre8 in all comer population in Subjects over 18 years old who are undergoing a clinically indicated coronary angiogram and angioplasty on de-novo lesion located in…
- Conditions
- Consecutive Subjects Who Are Suitable for a Coronary, Angioplasty of de Novo Lesion(s) in Native Coronary, Arteries Should be Screened for Eligibility., A Total Number of 200 Patients Fulfilling the Selection
- Trial name
- NCT01687075
- Testing
- CR8 a drug eluting coronary stent
- Where
- Israel
- Volunteers
- 215 people
- Sponsor
- Tel-Aviv Sourasky Medical Center
Follicular Lymphoma
A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma
The purpose of this study is to find out if lenalidomide when given along with rituximab can help to control the disease and also increase the length of your response (complete or partial response) compared to the standard of…
- Trial name
- RELEVANCE (NCT01650701)
- Testing
- Rituximab, Lenalidomide, Rituximab - CHOP
- Where
- 35 sites in Australia, Belgium and 6 more
- Volunteers
- 1,030 people
- Sponsor
- The Lymphoma Academic Research Organisation